Schedule a consultation to explore how MATTR can support your metabolic health, body composition, and long-term wellness.
Ryan said that "we do need better evidence" around whether some individuals can maintain weight loss after coming off GLP-1s, but she thinks what "Calibrate is doing is sharing the decision-making with the patient and trying to adapt to the environment where drugs may not always be available." Since Calibrate has come onto the market, results were published from a much larger, peer-reviewed study funded by the Ozempic manufacturer Novo Nordisk in 2022
According to MEDVis website disclosures, patients typically experience weight loss of approximately one to two pounds per week after the first four weeks when combined with dietary and lifestyle changes
Patients who still prefer non-surgical care can absolutely pursue it, but only if expectations match what the technology can realistically deliver
The patches have zero
But the trade-off is better adherence: when patients tolerate their medication, they stick with it